SOMETHING ABOUT US

Health Triage is a start-up born in Turin with the ambition to innovate the sector of technologies for cancer prevention, exploiting the extraordinary potential of Artificial Intelligence (AI).

Founded in 2020, it works to support doctors and healthcare facilities with reliable technologies capable of improving clinical decisions at the most critical momets.

Through proprietary deep learning algorithms and an interdisciplinary approach that integrates clinical, technical, and scientific expertise, Health Triage designs devices capable of automating part of the diagnostic process, reducing workloads, and improving the quality of diagnoses.

The company is part of the Fin Posillipo S.p.A. group, an industrial group with over 30 companies and an international presence in Europe, North Africa, the Middle East, Latin America, and Asia. With more than 800 employees and €800 million in turnover in the healthcare sector, the group operates across the entire clinical research supply chain.

Health Triage is currently engaged in two main projects:

BreastNegative, a medical device that automatically identifies negative mammograms in screening programs;

Prostate V-Bio, a non-invasive MRI-based systemcapable of classifying prostate cancer according to Gleason Grade.

Ethics, scientific rigor, and clinical validation are the foundation of every decision we make.

SOMETHING ABOUT US

Health Triage is a start-up born in Turin with the ambition to innovate the sector of technologies for cancer prevention, exploiting the extraordinary potential of Artificial Intelligence (AI).

It wants to position itself at the epicenter of the data revolution in the medical sector. Today an impressive amount of data is generated, in the order of zettabytes (1 zettabyte corresponds to a trillion bytes), relating to diagnoses, therapeutic paths, drugs, medical devices, digital images, results of laboratory analyzes and much more. Research activities focus on the development of new screening protocols and innovative diagnosis processes, exploiting Deep Learning to facilitate the acquisition of knowledge by new technologies through data, algorithms and artificial neural networks.

The use of digital Health Triage systems in healthcare allows you to completely innovate diagnostic processes with the aim of supporting medical staff and healthcare facilities with technological tools, capable of increasing quality, precision medicine and efficiency. Current research activities mainly concern the development of new automatic diagnosis technologies for oncology with a particular focus on the prevention of breast and prostate cancer.

Health Triage intends to accelerate innovation through the use of new AI models that need a lot of data and, for this reason, is promoting the creation of one of the first Data Lakes for the collection of health data, anonymized and pseudonymized, to make them available, through interconnected and integrated systems, facilitating the continuous improvement of the capabilities of their technologies.

THE COMPANY

Health Triage S.p.A. is an innovative start-up established at the beginning of 2020 and controlled by Fin Posillipo S.p.A., with additional participation from the ENEA Tech and Biomedical Foundation. Fin Posillipo S.p.A. oversees more than thirty companies, with offices
in Italy and Spain, serving Europe, North Africa, the Middle East, Latin America, Far East and Oceania.

The Group carries out research, development and marketing in the health sector, through subsidiaries, with a turnover of 800 million euros and more than 800 employees, offering direct support to Clinical Research Organization for clinical analyzes, research, scientific tests and preparatory activities for the launch of new products.